METHODS: An extensive literature review was conducted, focusing especially on global and regional guidelines for the evaluation and treatment of PsA. These form the basis of the consensus statements formulated. Additionally, an expert panel of key opinion leaders from the UAE reviewed these guidelines and available literature at an advisory board meeting to identify unmet needs, bridge clinical gaps in the UAE, and develop consensus statements for the evaluation and treatment of PsA.
RESULTS: The consensus statements were developed based on overarching principles for the management of PsA, evaluation of patients with PsA, and nonpharmacological approaches for the management of PsA. The overarching principles included adopting a targeted, multidisciplinary approach, along with collaboration between rheumatologists and dermatologists in cases of clinically significant skin involvement. The panel also highlighted the value of composite disease severity measures for characterizing clinical manifestations of PsA. In terms of nonpharmacological management approaches, lifestyle modification (comprising dietary change, exercise, and cessation of smoking) and psychotherapy were recommended.
CONCLUSIONS: The consensus statements will aid healthcare professionals in clinical decision-making in the context of PsA.
方法:进行了广泛的文献综述,特别关注PsA评估和治疗的全球和区域指南。这些构成了所制定的协商一致声明的基础。此外,由阿联酋主要意见领袖组成的专家小组在顾问委员会会议上审查了这些指南和现有文献,以确定未满足的需求,弥合阿联酋的临床差距,并为PsA的评估和治疗制定共识声明。
结果:共识声明是根据PsA管理的总体原则制定的,对PsA患者的评估,和非药物治疗PsA的方法。总体原则包括采取有针对性的,多学科方法,以及风湿病学家和皮肤科医生在临床上明显的皮肤受累情况下的合作。该小组还强调了复合疾病严重程度指标对表征PsA临床表现的价值。就非药物管理方法而言,改变生活方式(包括饮食改变,锻炼,并建议戒烟)和心理治疗。
结论:共识声明将帮助医疗保健专业人员在PsA背景下进行临床决策。